PSMA PET: the answer to MRI-occult prostate cancer… or another mirage? [PDF]
Wagner T +6 more
europepmc +1 more source
Focal therapy in localized prostate cancer: moving from therapeutic enthusiasm to structured stewardship. [PDF]
Masood S, Zarif S.
europepmc +1 more source
<sup>18</sup>F-labeled prostate-specific membrane antigen positron emission tomography/computed tomography vs. magnetic resonance imaging in diagnosis of prostate cancer A meta-analysis. [PDF]
Feng H, Su Y, Lu F.
europepmc +1 more source
Association of preoperative multiparametric MRI with oncological and functional outcomes following robot-assisted radical prostatectomy: a multicentre prospective study. [PDF]
Galante Romo MI +7 more
europepmc +1 more source
Multicenter Validation of a Risk Classification Cluster for Unfavorable Pathology in Prostatectomy Specimens of Patients with an Active Surveillance Expanded Inclusion Criteria. [PDF]
Romero MG +8 more
europepmc +1 more source
PI-RADS v2.1 for prostate MRI: current applications, ongoing debates, and synergies with advanced technologies-a narrative review. [PDF]
Zhang S, Wang X, Guo M, Chen F.
europepmc +1 more source
Patient and Technology Selection for Focal Therapy in Prostate Cancer. [PDF]
Dinckal M +3 more
europepmc +1 more source
Micro-ultrasonography- vs MRI-targeted biopsy in prostate cancer: Updated systematic review and meta-analysis. [PDF]
Micheleto JPC +12 more
europepmc +1 more source
Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial. [PDF]
Lim RP +9 more
europepmc +1 more source
The Precision Paradox in Prostate Cancer Diagnostics: Grade Migration, Risk Misclassification, and Overtreatment in the mpMRI-Targeted Biopsy Era. [PDF]
Micillo A +5 more
europepmc +1 more source

